Search Results

TAE684 100mg 100mg  | Purity Not Available

Adooq Bioscience

TAE684 is a inhibitor of ALK and also a potent inhibitor of LRRK2 kinase activity (IC(50) of 7.8nM against wild-type LRRK2, 6.1nM against the G2019S mutant).

More Information Supplier Page

TAE684 10mg 10mg  | Purity Not Available

Adooq Bioscience

TAE684 is a inhibitor of ALK and also a potent inhibitor of LRRK2 kinase activity (IC(50) of 7.8nM against wild-type LRRK2, 6.1nM against the G2019S mutant).

More Information Supplier Page

NVP-BHG712 50mg 50mg  | Purity Not Available

Adooq Bioscience

NVP-BHG712 is a selective inhibitor of EphB4 kinase that exhibits selectivity for EphB4 over more than 40 other kinases in vitro, including FGFR3.

More Information Supplier Page

NVP-BHG712 5mg 5mg  | Purity Not Available

Adooq Bioscience

NVP-BHG712 is a selective inhibitor of EphB4 kinase that exhibits selectivity for EphB4 over more than 40 other kinases in vitro, including FGFR3.

More Information Supplier Page

Phenprocoumon 5mg 5mg  | Purity Not Available

Adooq Bioscience

Phenprocoumon is a vitamin K antagonist that inhibits coagulation by blocking synthesis of coagulation factors II, VII, IX and X. It is used for the prophylaxis and treatment of thromboembolic disorders (thrombosis/pulmonary embolism).

More Information Supplier Page

Phenprocoumon 25mg 25mg  | Purity Not Available

Adooq Bioscience

Phenprocoumon is a vitamin K antagonist that inhibits coagulation by blocking synthesis of coagulation factors II, VII, IX and X. It is used for the prophylaxis and treatment of thromboembolic disorders (thrombosis/pulmonary embolism).

More Information Supplier Page

Phenprocoumon 10mg 10mg  | Purity Not Available

Adooq Bioscience

Phenprocoumon is a vitamin K antagonist that inhibits coagulation by blocking synthesis of coagulation factors II, VII, IX and X. It is used for the prophylaxis and treatment of thromboembolic disorders (thrombosis/pulmonary embolism).

More Information Supplier Page